Diabetic macular edema risk seen with thiazolidinediones

NEW YORK (Reuters Health) - A large retrospective population-based study of patients from the United Kingdom with type 2 diabetes detected a higher incidence of diabetic macular edema at one- and 10-year follow-up in those taking a thiazolidinedione to control blood sugar.

Full Story →